Giovanni Sarnelli is Full Professor of Gastroenterology at the University of Naples "Federico II" and Head of the Unit of Digestive and Nutritional Pathophysiology at the University Hospital Federico II. His research focuses on neurogastroenterology, gut inflammation, and microbiome-based therapies, with key contributions in cannabinoid pharmacology and next-generation probiotics, including several international patents. He serves on national and international expert panels for gastrointestinal disease guidelines and is a member of the Rome Foundation, co-chairing the Rome V chapter on pharmacology. A founding member of the Italian Society for Precision Medicine and the Path-2 Task Force on Th2-mediated diseases, he combines clinical leadership with active roles in academic governance. Giovanni has authored over 150 scientific papers and lectures in multiple degree and specialty programs, promoting a multidisciplinary approach to gut health and disease.

Mauro D'Amato is Professor of Medical Genetics at the Department of Medicine and Surgery at LUM University in Casamassima - Italy, and Ikerbasque Research Professor and Head of the Gastrointestinal Genetics Lab in CIC bioGUNE, Bilbao - Spain. His career has developed through an international trajectory, holding research and academic positions at international institutions across UK, Sweden, Spain and Australia. Professor D’Amato has >25 years research experience in the field of human genetics and complex diseases, with activities geared towards a translational application for therapeutic precision in gastroenterology. His team, the Gastrointestinal Genetics Laboratory, combine leading expertise in genomic, computational and pre-clinical research, and have linked specific genes and pathogenetic mechanisms to a number of gastrointestinal diseases including inflammatory bowel disease, microscopic colitis and irritable bowel syndrome. Professor D’Amato has an H-index of 78, has edited 2 books and published extensively in the field of human genetics and gastrointestinal disease.